Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
Sponsor: Novo Nordisk A/S
Summary
This study tests the prevalence and characteristics of overlapping obesity, type 2 diabetes (T2D), cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic dysfunction-associated steatotic liver disease \[MASLD/Metabolic Dysfunction-Associated Steatohepatitis (MASH)\], osteoarthritis, hypertension, and dyslipidemia. The purpose of the study is to measure how common cardiovascular, kidney, and metabolic diseases are in the Korean adult population and how often they occur together (overlap) over time (2013-2023). Participants will not receive any study medicine as this is an observational analysis of existing survey data. The study does not involve a new investigational drug; it analyses health and outcome data collected in routine practice and national surveys.
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
800000
Start Date
2026-06-08
Completion Date
2026-08-03
Last Updated
2026-06-29
Healthy Volunteers
Not specified
Interventions
No treatment given
No treatment given
Locations (1)
Novo Nordisk Pharma Korea, Ltd.
Seoul, South Korea